These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8936720)

  • 1. [Piracetam, nimodipine and tacrine in the pharmacologic treatment of dementia: bibliographic review].
    Ojer Tsakiridu D; Dosantos Hernández JO; Larrabe Medina J; Sánchez Casado JI; Sologuren Echenagusia A
    Aten Primaria; 1996 Sep; 18(5):257-60, 262-4. PubMed ID: 8936720
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction.
    Zongfang Z; Wenjing L; Zhaomin C; Lei Z
    Pak J Pharm Sci; 2020 Sep; 33(5(Special)):2405-2411. PubMed ID: 33832882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing practice with cognition enhancers in outpatient care: are there differences regarding type of dementia?--Results of a representative survey in lower Saxony, Germany.
    Stoppe G; Sandholzer H; Staedt J; Winter S; Kiefer J; Rüther E
    Pharmacopsychiatry; 1996 Jul; 29(4):150-5. PubMed ID: 8858714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam].
    Herrmann WM; Kern U
    Nervenarzt; 1987 Jun; 58(6):358-64. PubMed ID: 3302738
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
    McSwain ML; Forman LM
    J Clin Psychopharmacol; 1995 Aug; 15(4):284. PubMed ID: 7593712
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Tacrine for treatment of sleep disturbance in dementia".
    Gillman PK
    J Am Geriatr Soc; 1997 Oct; 45(10):1286. PubMed ID: 9329501
    [No Abstract]   [Full Text] [Related]  

  • 8. Nootropics: preclinical results in the light of clinical effects; comparison with tacrine.
    Mondadori C
    Crit Rev Neurobiol; 1996; 10(3-4):357-70. PubMed ID: 8978986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term tacrine treatment effects.
    Knopman D; Schneider L; Davis K; Gracon S; Smith F
    Neurology; 1998 Feb; 50(2):567-8. PubMed ID: 9484404
    [No Abstract]   [Full Text] [Related]  

  • 10. Dementia.
    Warner J; Butler R; Arya P
    Clin Evid; 2004 Dec; (12):1361-90. PubMed ID: 15865724
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and tolerability of tacrine in nursing home residents with Alzheimer's dementia.
    Woo JK; Lantz MS; Marchello V; Libow LS
    J Am Geriatr Soc; 1996 Nov; 44(11):1411-2. PubMed ID: 8909368
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the randomized controlled trials of tacrine in the treatment of Alzheimer's disease: methodologic considerations.
    Conway EL
    Clin Neuropharmacol; 1998; 21(1):8-17. PubMed ID: 9579280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed-model analysis of incomplete longitudinal data from a high-dose trial of tacrine (Cognex) in Alzheimer's patients.
    Smith F
    J Biopharm Stat; 1996 Mar; 6(1):59-67. PubMed ID: 8838779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of piracetam in cognitive impairment: a meta-analysis.
    Waegemans T; Wilsher CR; Danniau A; Ferris SH; Kurz A; Winblad B
    Dement Geriatr Cogn Disord; 2002; 13(4):217-24. PubMed ID: 12006732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study].
    Mateo D; Giménez-Roldán S
    Neurologia; 1996 Jan; 11(1):16-9. PubMed ID: 8714171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic.
    Lyketsos CG; Corazzini K; Steele CD; Kraus MF
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):67-73. PubMed ID: 8845704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piracetam in the treatment of acute stroke.
    Orgogozo JM
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():25-32. PubMed ID: 10338105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.
    Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ
    Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind investigation of piracetam (nootropil) versus placebo in the memory of geriatric inpatients.
    Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
    Psychopharmacol Bull; 1978 Jan; 14(1):23-5. PubMed ID: 343146
    [No Abstract]   [Full Text] [Related]  

  • 20. Diffuse Lewy body disease: a common yet misdiagnosed dementia in which neuroleptics may be contraindicated.
    Scarbrough TJ
    Tenn Med; 1998 Feb; 91(2):58-60. PubMed ID: 9478123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.